A trial to evaluate the safety, immunogenicity and clinical activity of a helper peptide vaccine plus PD-1 blockade

被引：0
|
作者：
Slingluff, Craig, Jr. [1 ]
Gaughan, Elizabeth [1 ]
Grosh, William [1 ]
Petroni, Gina [1 ]
Bullock, Kimberly [1 ]
机构：
[1] Univ Virginia, Charlottesville, VA USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2017年 / 5卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P227
引用
收藏
页数：1
相关论文
共 50 条
  • [21] A dose-escalation clinical trial to evaluate the safety and immunogenicity of a replication-defective HIV-1 vaccine-HIVAX
    Tung, F.
    Tung, J.
    Fischl, M.
    RETROVIROLOGY, 2012, 9
  • [22] A dose-escalation clinical trial to evaluate the safety and immunogenicity of a replication-defective HIV-1 vaccine-HIVAX
    F Tung
    J Tung
    M Fischl
    Retrovirology, 9
  • [23] Efficacy of PD-1/PD-L1 blockade monotherapy in clinical trials
    Zhao, Bin
    Zhao, Hong
    Zhao, Jiaxin
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12
  • [24] Preclinical Data Supporting Antitumor Activity of PD-1 Blockade
    Curran, Michael A.
    CANCER JOURNAL, 2018, 24 (01): : 2 - 6
  • [25] A phase II study to evaluate safety and efficacy of PD-1 blockade plus anti-EGFR target therapy plus chemotherapy in patients with advanced penile squamous cell carcinoma
    Shi, Y.
    An, X.
    Yan, R.
    Yao, K.
    Xue, C.
    Guo, S.
    Liu, T.
    Li, J.
    Ma, H.
    Tian, L.
    Zhou, F.
    Shi, Y.
    Han, H.
    EUROPEAN UROLOGY, 2021, 79 : S933 - S933
  • [26] Effect of the hairpin structure of peptide inhibitors on the blockade of PD-1/PD-L1 axis
    Wang, Kai
    Song, Yanhui
    Su, Yu
    Liang, Yuting
    Wang, Liping
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2020, 527 (02) : 453 - 457
  • [27] Clinical trial of the safety and immunogenicity of three doses of a Leishmania vaccine.
    Firooz, A
    Alimohammadian, MH
    Khamesipour, A
    Dowlati, Y
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1998, 110 (04) : 671 - 671
  • [28] Antitumor activity, immunogenicity and safety of a novel PD-1 vaccine in combination with two chimeric HER-2 peptide vaccine in syngeneic Balb/c, C57Bl/6 models and in beagle dogs
    Kaumaya, P. T. P.
    Overholser, J.
    Guo, L.
    Yang, Y.
    Penichet, M.
    Sayanjali, B.
    Ede, N.
    Chong, L.
    Bekaii-Saab, T.
    ANNALS OF ONCOLOGY, 2019, 30
  • [29] Immune Checkpoint Blockade in Cancer Immunotherapy: Mechanisms, Clinical Outcomes, and Safety Profiles of PD-1/PD-L1 Inhibitors
    Yan Yan
    Li Zhang
    Yun Zuo
    Heya Qian
    Chang Liu
    Archivum Immunologiae et Therapiae Experimentalis, 2020, 68
  • [30] Immune Checkpoint Blockade in Cancer Immunotherapy: Mechanisms, Clinical Outcomes, and Safety Profiles of PD-1/PD-L1 Inhibitors
    Yan, Yan
    Zhang, Li
    Zuo, Yun
    Qian, Heya
    Liu, Chang
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2020, 68 (06)
12345